title: Wwox inactivation enhances mammary tumorigenesis.
abstract: Breast cancer is the leading cause of cancer-related death in women worldwide. Expression of the WWOX tumor suppressor is absent or reduced in a large proportion of breast tumors suggesting that loss of WWOX may contribute to breast tumorigenesis. Wwox-deficient mice die by 3-4 weeks of age precluding adult tumor analysis. To evaluate the effect of WWOX-altered expression on mammary tumor formation, the Wwox-heterozygous allele was back crossed onto the C3H mammary tumor-susceptible genetic background (Wwox(C3H)+/-) and incidence of mammary tumor formation was evaluated. Although 50% of the female Wwox(C3H)+/- mice developed mammary carcinomas, only 7% of Wwox(C3H)+/+ mice did. Intriguingly, mammary tumors in Wwox(C3H)+/- mice frequently lost WWOX protein expression suggesting a genetic predisposition toward mammary tumorigenesis. Immunohistochemical staining of hormone receptors revealed loss of estrogen receptor-α (ER) and progesterone receptor in the majority of these tumors. In vitro, depletion of WWOX in MCF7 ER-positive cells led to reduced ER expression and reduced sensitivity to tamoxifen and estrogen treatment and was associated with enhanced survival and anchorage-independent growth. Finally, cDNA array analyses of murine normal mammary epithelial cells and mammary tumors identified 163 significantly downreguated and 129 upregulated genes in the tumors. The majority of differentially expressed genes were part of pathways involved in cellular movement, cell-to-cell signaling and interaction, cellular development, cellular growth and proliferation and cell death. These changes in gene expression of mouse mammary tumors in Wwox(C3H)+/- mice resemble, at least in part, human breast cancer development. Our findings demonstrate the critical role that the WWOX tumor suppressor gene has in preventing tumorigenesis in breast cancer.
authors.affiliation: The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
authors.forename: S K
authors.initials: SK
authors.lastname: Abdeen
authors.forename: Z
authors.initials: Z
authors.lastname: Salah
authors.forename: B
authors.initials: B
authors.lastname: Maly
authors.forename: Y
authors.initials: Y
authors.lastname: Smith
authors.forename: R
authors.initials: R
authors.lastname: Tufail
authors.forename: M
authors.initials: M
authors.lastname: Abu-Odeh
authors.forename: N
authors.initials: N
authors.lastname: Zanesi
authors.forename: C M
authors.initials: CM
authors.lastname: Croce
authors.forename: Z
authors.initials: Z
authors.lastname: Nawaz
authors.forename: R I
authors.initials: RI
authors.lastname: Aqeilan
mesh_terms: D000483:Alleles; D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism; D016923:Cell Death; D045744:Cell Line, Tumor; D003433:Crosses, Genetic; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D015674:Mammary Neoplasms, Animal / Q000378:metabolism*; D051379:Mice; D008809:Mice, Inbred C3H; D008822:Mice, Transgenic; D010088:Oxidoreductases / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism; D015398:Signal Transduction; D000074584:WW Domain-Containing Oxidoreductase
chemical_list: D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D010088:Oxidoreductases; D000074584:WW Domain-Containing Oxidoreductase; C428130:Wwox protein, mouse